ISSN: 2161-0932
Seval Ay*, Deniz Tataroğlu Özyükseler, Mustafa Başak, Özgecan Dülgar, Serdar Arıcı, Mahmut Emre Yıldırım, Mahmut Gümüş
Ovarian cancer is the second most common gynecologic cancer. Furthermore, it is associated with the highest mortality of gynecologic cancers in the western world. According to the results, every year, 230 000 new ovarian cancer patients will be diagnosed, and 150 000 of those are likely to die. Due to the lack of warning symptoms and the absence of screening recommendations, approximately 70% of cases diagnosed with advanced disease.